Journal of the American Academy of Dermatology
Volume 56, Issue 4 , Pages 629-634 , April 2007

The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: A case-control study

  • Jonathan Shapiro, MD, MHA

      Affiliations

    • From Maccabi Healthcare Services
    • Corresponding Author InformationReprint requests: Jonathan Shapiro, MD, MHA, Maccabi Health Services, Ben Gurion 140, Ramat Hasharon, Israel.
    • ,
  • Arnon D. Cohen, MD, MHA

      Affiliations

    • Clalit Health Services
    • ,
  • Michael David, MD

      Affiliations

    • Dermatology Department, Rabin Medical Center
    • ,
  • Emilia Hodak, MD

      Affiliations

    • Dermatology Department, Rabin Medical Center
    • ,
  • Gabi Chodik, MHA

      Affiliations

    • From Maccabi Healthcare Services
    • ,
  • Anna Viner, MSC

      Affiliations

    • From Maccabi Healthcare Services
    • ,
  • Eyal Kremer, MD

      Affiliations

    • From Maccabi Healthcare Services
    • ,
  • Anthony Heymann, MD, MHA

      Affiliations

    • From Maccabi Healthcare Services

,Accepted 18 September 2006.

References 

  1. Vessey MP, Painter R, Powell J. Skin disorders in relation to oral contraception and other factors, including age, social class, smoking and body mass index. Findings in a large cohort study. Br J Dermatol. 2000;143:815–820
  2. Plunkett A, Marks R. A review of the epidemiology of psoriasis vulgaris in the community. Australas J Dermatol. 1998;39:225–232
  3. Mordovtsev VN, Sergeev AS, Alieva PM, Koshechkin VA. [Association of psoriasis with hyperlipoproteinemia, stroke, ischemic heart disease, myocardial infarct and diabetes mellitus]. Vestn Dermatol Venerol. 1982;9:4–8Russian
  4. Mallbris L, Akre O, Granath F, Yin L, Lindelof B, Ekbom A, et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol. 2004;19:225–230
  5. Sundharam ASR, Agarwal PS. Psoriasis and diabetes mellitus. Indian J Dermatol Venereol Leprol. 1980;46:158–162
  6. Alexander Emy PJ, Pal GS, Kamath N, Kuruvilla M. Disease concomitance in psoriasis: a clinical study of 61 cases. Indian J Dermatol Venereol Leprol. 2001;67:66–68
  7. Herron MD, Hinckley M, Hoffman MS, Papenfuss J, Hansen CB, Callis KP, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol. 2005;141:1527–1534
  8. Lindegard B. Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica. 1986;172:298–304
  9. Fortes C, Mastroeni S, Leffondre K, Sampogna F, Melchi F, Mazzotti E, et al. Relationship between smoking and the clinical severity of psoriasis. Arch Dermatol. 2005;141:1580–1584
  10. Chodorowska G, Kwiatek J. Psoriasis and cigarette smoking. Ann Univ Mariae Curie Sklodowska [Med]. 2004;59:535–538
  11. Naldi L, Chatenoud L, Linder D, Belloni Fortina A, Peserico A, Virgili AR, et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol. 2005;125:61–67
  12. Sela BA. [Dermatological manifestations of smoking]. Harefuah. 2002;141:736–740760. Hebrew
  13. Naldi L, Peli L, Parazzini F. Association of early-stage psoriasis with smoking and male alcohol consumption: evidence from an Italian case-control study. Arch Dermatol. 1999;135:1479–1484
  14. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol. 1995;32:982–986
  15. Inerot A, Enerback C, Enlund F, Martinsson T, Samuelsson L, Wahlstrom J, et al. Collecting a set of psoriasis family material through a patient organisation; clinical characterisation and presence of additional disorders. BMC Dermatol. 2005;5:10
  16. Porat A, R.G., Raskin Segal A,Vitzman R. Quality measurements for community based medicine in Israel. In: Report to the public for years 2002-2004. Ministry of Health in Israel: 2004. p. 8.
  17. Centers for Disease Control and Prevention. 1999-2001 National Health Interview survey and 1999-2000 National Health and Nutrition Examination survey estimates projected to 2002. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2003. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2003. Available at: http://www.cdc.gov/diabetes/pubs/factsheet.htm. Accessed November 30, 2003.
  18. Rhew EY, Ramsey-Goldman R. Premature atherosclerotic disease in systemic lupus erythematosus—role of inflammatory mechanisms. Autoimmun Rev. 2006;5:101–105
  19. Asanuma Y, Chung CP, Oeser A, Shintani A, Stanley E, Raggi P, et al. Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors. J Rheumatol. 2006;33:539–545Epub 2006 Feb 1
  20. Leong TT, Fearon U, Veale DJ. Angiogenesis in psoriasis and psoriatic arthritis: clues to disease pathogenesis. Curr Rheumatol Rep. 2005;7:325–329
  21. Rogers MS, D'Amato RJ. The effect of genetic diversity on angiogenesis. Exp Cell Res. 2006;312:561–574
  22. Simons RD. Additional studies on psoriasis in the tropics and in starvation camps. J Invest Dermatol. 1949;12:285–294
  23. Lithell H, Bruce A, Gustafsson IB, Hoglund NJ, Karlstrom B, Ljunghall K, et al. A fasting and vegetarian diet treatment trial on chronic inflammatory disorders. Acta Derm Venereol. 1983;63:397–403
  24. Spiera H, Lefkovits AM, Oreskes I. A dietary regimen in the treatment of psoriasis. Br J Dermatol. 1971;85:277–285
  25. Horrobin DF. Low prevalences of coronary heart disease (CHD), psoriasis, asthma and rheumatoid arthritis in Eskimos: are they caused by high dietary intake of eicosapentaenoic acid (EPA), a genetic variation of essential fatty acid (EFA) metabolism or a combination of both?. Med Hypotheses. 1987;22:421–428
  26. Uyanik BS, Ari Z, Onur E, Gunduz K, Tanulku S, Durkan K. Serum lipids and apolipoproteins in patients with psoriasis. Clin Chem Lab Med. 2002;40:65–68

 Funding sources: None.Conflicts of interest: None identified.

PII: S0190-9622(06)02543-6

doi: 10.1016/j.jaad.2006.09.017

Journal of the American Academy of Dermatology
Volume 56, Issue 4 , Pages 629-634 , April 2007

Article Tools

* Image Usage & Resolution